Humana Inc. (NYSE:HUM) Shares Sold by Adage Capital Partners GP L.L.C.

Adage Capital Partners GP L.L.C. lowered its holdings in Humana Inc. (NYSE:HUM - Free Report) by 38.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 55,962 shares of the insurance provider's stock after selling 35,486 shares during the quarter. Adage Capital Partners GP L.L.C.'s holdings in Humana were worth $14,198,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Vanguard Group Inc. raised its stake in Humana by 15.8% in the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after buying an additional 1,751,857 shares in the last quarter. Dodge & Cox increased its holdings in shares of Humana by 106.7% in the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after acquiring an additional 5,264,045 shares during the period. Pzena Investment Management LLC raised its position in shares of Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after acquiring an additional 1,103,132 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Humana by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock worth $729,658,000 after purchasing an additional 63,562 shares during the last quarter. Finally, Invesco Ltd. boosted its position in Humana by 29.8% during the fourth quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock valued at $608,348,000 after purchasing an additional 550,692 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

HUM has been the subject of several analyst reports. Piper Sandler increased their price target on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research report on Wednesday, January 15th. StockNews.com downgraded shares of Humana from a "buy" rating to a "hold" rating in a research note on Thursday. Mizuho increased their price objective on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Truist Financial boosted their target price on Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a research note on Friday, April 11th. Finally, Raymond James upgraded Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target for the company in a research note on Thursday. Eighteen analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $287.76.

Humana Stock Performance

NYSE HUM traded up $2.17 during mid-day trading on Friday, reaching $258.21. 1,740,020 shares of the stock were exchanged, compared to its average volume of 1,753,030. The company has a market capitalization of $31.16 billion, a P/E ratio of 25.95, a P/E/G ratio of 2.05 and a beta of 0.49. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The business's 50 day moving average is $266.17 and its 200-day moving average is $270.73. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to analysts' expectations of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The company's quarterly revenue was up 8.4% on a year-over-year basis. During the same period last year, the firm earned $7.23 EPS. On average, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.37%. The ex-dividend date of this dividend is Friday, June 27th. Humana's payout ratio is presently 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.